首页> 外文期刊>American Journal of Physiology >Evidence of human milk oligosaccharides in maternal circulation already during pregnancy: a pilot study
【24h】

Evidence of human milk oligosaccharides in maternal circulation already during pregnancy: a pilot study

机译:母乳低聚糖在怀孕期间已经在母体循环中的证据:一项初步研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Human milk oligosaccharides (HMOs) are bioactive glycans linked with health benefits to both the breast-fed infant and lactating mother. We hypothesized that HMOs are present before lactation, already during pregnancy, and are influenced by maternal body composition. In a pilot study, we investigated individual and temporal variations in HMO composition and concentration in maternal serum at gestational weeks 10-14 (visit 1), 20-24 (visit 2), and 30-35 (visit J) (VI, V2, and V3, respectively) and associations with maternal body composition. HMOs were quantified by HPLC and confirmed by enzymatic digest and mass spectrometry. Associations of maternal prepregnancy body mass index (BMI), subcutaneous adipose tissue (SAT) thickness, and adipokines with absolute and relative HMO concentrations were analyzed by Spearman correlation. We identified 16 HMOs and 2 oligosaccharides not common to human milk.
机译:母乳低聚糖 (HMO) 是生物活性聚糖,对母乳喂养的婴儿和哺乳期母亲都有健康益处。我们假设 HMO 在哺乳期之前就已经存在,已经在怀孕期间,并且受到母体成分的影响。在一项初步研究中,我们调查了妊娠第 10-14 周(第 1 次访视)、20-24 周(第 2 次访视)和第 30-35 周(访视 J)(分别为 VI、V2 和 V3)母体血清中 HMO 组成和浓度的个体和时间变化以及与母体成分的关联。HMOs通过HPLC定量,并通过酶消化和质谱法进行确认。采用Spearman相关性分析孕前体重指数(BMI)、皮下脂肪组织(SAT)厚度和脂肪因子与HMO绝对和相对浓度的相关性。我们鉴定了 16 种 HMO 和 2 种母乳中不常见的低聚糖。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号